1. Home
  2. OII vs APLS Comparison

OII vs APLS Comparison

Compare OII & APLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Oceaneering International Inc.

OII

Oceaneering International Inc.

HOLD

Current Price

$34.00

Market Cap

2.3B

Sector

Energy

ML Signal

HOLD

Logo Apellis Pharmaceuticals Inc.

APLS

Apellis Pharmaceuticals Inc.

HOLD

Current Price

$17.48

Market Cap

2.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
OII
APLS
Founded
1964
2009
Country
United States
United States
Employees
N/A
N/A
Industry
Oilfield Services/Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.3B
2.7B
IPO Year
1994
2015

Fundamental Metrics

Financial Performance
Metric
OII
APLS
Price
$34.00
$17.48
Analyst Decision
Hold
Buy
Analyst Count
4
21
Target Price
$31.33
$31.65
AVG Volume (30 Days)
1.4M
1.8M
Earning Date
04-22-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
142.36
112.50
EPS
3.49
0.20
Revenue
$2,784,156,000.00
$1,003,782,000.00
Revenue This Year
$3.48
N/A
Revenue Next Year
$5.62
$18.21
P/E Ratio
$9.72
$89.68
Revenue Growth
4.62
28.46
52 Week Low
$15.46
$16.10
52 Week High
$39.00
$30.48

Technical Indicators

Market Signals
Indicator
OII
APLS
Relative Strength Index (RSI) 49.65 27.58
Support Level $21.51 $17.16
Resistance Level $36.66 $20.42
Average True Range (ATR) 1.58 0.73
MACD -0.45 -0.16
Stochastic Oscillator 25.11 12.94

Price Performance

Historical Comparison
OII
APLS

About OII Oceaneering International Inc.

Oceaneering International Inc is a provider of engineered services and products and robotic solutions to the offshore energy, defense, aerospace, manufacturing, and entertainment industries. A majority of its products are produced for the offshore oil and gas market. The company's business segments are Integrity Management and Digital Solutions, Subsea Robotics, Manufactured Products, Offshore Projects Group, and Aerospace and Defense Technologies. Maximum revenue is generated from its Subsea Robotics segment, which provides remotely operated vehicles (ROVs) for drill support and vessel-based services, underwater surveys, tooling, and other activities. Geographically, the company derives its key revenue from the United States, followed by Africa, Norway, Brazil, and other regions.

About APLS Apellis Pharmaceuticals Inc.

Apellis Pharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel therapeutic compounds to treat diseases with high unmet needs through the inhibition of the complement system, which is an integral component of the immune system, at the level of C3, the central protein in the complement cascade.

Share on Social Networks: